Related Experiment Video
Updated: Aug 11, 2025

16:11
Protocols for Implementing an Escherichia coli Based TX-TL Cell-Free Expression System for Synthetic Biology
Published on: September 16, 2013
64.3K
Automating the design-build-test-learn cycle towards next-generation bacterial cell factories
Nicolás Gurdo1, Daniel C Volke1, Douglas McCloskey1
1The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kongens, Lyngby, Denmark.
New Biotechnology
|February 3, 2023
Summary
Automation is revolutionizing synthetic biology by accelerating microbial cell factory construction. A fully automated design-build-test-learn cycle (DBTLc) promises faster, high-throughput development of next-generation bacterial cell factories.
Area of Science:
- Synthetic Biology
- Metabolic Engineering
- Automation
Background:
- Automation is increasingly vital in synthetic biology, significantly speeding up microbial cell factory development over the last two decades.
- Integrating advanced tools like genome engineering and analytical techniques into the design-build-test-learn cycle (DBTLc) is transforming metabolic engineering from artisanal work to automated workflows.
Purpose of the Study:
- To provide a perspective on utilizing a fully automated DBTLc for constructing next-generation bacterial cell factories.
- To review innovative toolsets and approaches that advance each stage of the automated DBTLc.
- To highlight recent automation efforts paving the way for autonomous synthetic biology pipelines.
Main Methods:
- Review of groundbreaking technologies in genome engineering and analytical techniques.
- Analysis of innovative toolsets and approaches within each segment of the DBTLc.
- Examination of recent advancements in the automation of the DBTLc.
Main Results:
- The integration of advanced tools into the DBTLc is shifting metabolic engineering towards automated workflows.
- Innovative toolsets and approaches have pushed the boundaries in each segment of the DBTLc.
- Recent automation efforts indicate a future with fully autonomous pipelines for synthetic biology.
Conclusions:
- A fully automated DBTLc can enable the fast, high-throughput construction of next-generation bacterial cell factories.
- The ongoing automation of the DBTLc heralds a fully autonomous pipeline for synthetic biology.
- This approach represents a significant paradigm shift in metabolic engineering and synthetic biology development.

